Extraordinary General Meeting of shareholders to be held on October 28, 2024roman4682Sep 16, 20240 min readUpdated: Dec 18, 202409-17-2024.pdfDownload PDF • 363KB
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025
